Hypoglycemic Coma in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib / 대한내과학회지
Korean Journal of Medicine
;
: 501-504, 2014.
Artículo
en Coreano
| WPRIM
| ID: wpr-176485
ABSTRACT
We present a patient with type 2 diabetes mellitus and metastatic renal cell carcinoma who developed severe hypoglycemia and metabolic encephalopathy after sunitinib treatment. Sunitinib, a multi-target tyrosine kinase inhibitor, is used to treat metastatic renal cell carcinoma. Sunitinib-induced hypoglycemia has been reported and there are rare case reports of severe hypoglycemia due to sunitinib. Therefore, glycemic control should be monitored closely in diabetic patients treated with sunitinib.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Encefalopatías Metabólicas
/
Proteínas Tirosina Quinasas
/
Carcinoma de Células Renales
/
Coma
/
Diabetes Mellitus Tipo 2
/
Hipoglucemia
Límite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS